Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig

Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain

(2011) A. L. Krarup et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effect of Mucosal TRPV1 Inhibition in Allergic Rhinitis

(2011) Lisa Alenmyr et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects

(2011) Patrick Round et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial

(2011) Michael C. Rowbotham et al.   PAIN

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Osmolality-induced tuning of action potentials in trigeminal ganglion neurons

(2009) Lei Chen et al.   NEUROSCIENCE LETTERS

Mechanisms and mediators of nasal symptoms in non-allergic rhinitis

(2008) R. J. Salib et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans

(2008) Narender R. Gavva et al.   PAIN

The emerging role of TRPV1 in diabetes and obesity

(2007) Anish Suri et al.   TRENDS IN PHARMACOLOGICAL SCIENCES